Conference 2026

ATiO Conference 2026 | 24. - 26. June

Latest ATiO Conference Impressions

Keynote Speakers

Conference Agenda & Schedule

ATiO Emerging Company Pitch Contest

Location And Host City

Conference Sponsors

Latest ATiO Conference Impressions

"The ATiO gathering has finally brought together the right stakeholders to bring innovation from the bench to the bedside. We need more initiatives like this and I can’t wait to contribute to the next efforts of this vibrant and diverse community of professionals in the regenerative medicine theatre."

- Prof. Dr. Lorenzo Moroni, FYAE, Director, MERLN 

 

"This inaugural ATiO meeting was a sensational start for a new organization aimed at pushing the frontier of biologics in a highly collaborative intimate setting of leaders in our field. I look forward to acting on some of the many important ideas presented."

- Scott Bruder PhD, CEO & Founder, Bruder Consulting & Venture Group

 

"The ATIO Conference was a pleasure to attend with contributions ranging from key opinion leaders to pitches from start ups with unique solutions. Furthermore, clinical cases that allowed us to see where current treatment stands as well as revealing the next generation of biomaterials, devices and cell therapies make this a unique forum."

- Aylvin Dias PhD, Principal Scientist, dsm-firmenich

 

"It was wonderful to see the diverse stakeholders meaningfully engaged in constructive dialogue. It is highly unusual to have an environment where industry and academia can converse so freely and constructively."

- Prof. David Hunter PhD, Florance and Cope Chair of Rheumatology, University of Sydney

 

"It was a superb departure from conventional meetings, brining together academics, clinicians, bio tech companies, investors, and entrepreneurs in a dynamic, interactive format. I was especially impressed by the breadth of topics and the concise, impactful presentations, which encouraged clarity and engagement. The plenary sessions fostered meaningful interactions at every turn. Since my last attendance four years ago, it's remarkable how the conference has evolved with significantly increased participation by industry and start-ups. I eagerly anticipate future ATiO meetings and contributing to the ongoing growth and innovation of this exceptional communty"  

- Prof. Christopher H. Evans PhD, John and Posy Krehbiel Professor of Orthopaedics, Director, Rehabilitation Medicine Research Center & Musculoskeletal Gene Therapy Laboratoy, Mayo Clinic

 

“An absolute eye-opener when it comes to understanding the extent to which regenerative medicine has come in the past decade. We are truly on the task of a revolution and the application of biological solutions to chronic diseases and infection in orthopedics. A must attend event if you’re lucky enough to be invited.”

- Prof. Stefano A. Bini, M.D., Maria Manetti Shrem Endowed Professor, Chief Technology Officer, Department of Orthopaedic Surgery, University of California San Francisco (UCSF);  Founder and Chair, UCSF Digital Orthopedics Conference (DOCSF); Founder and President, Personalized Arthroplasty Society (PAS)

 

Keynote Speakers

 

 

 
 
 

Prof. Dr. Heyo K. Kroemer 

  • CEO @Charité - Universitätsmedizin Berlin

  • Member @German National Academy of Sciences Leopoldina

  • Board Member @Association of German University Hospitals (VUD)

     

Professor Dr Heyo K. Kroemer was born in Leer, Germany, in 1960. He studied pharmacy at the Technical University of Braunschweig from 1978 to 1983, receiving his habilitation in pharmacology and toxicology from the Eberhard Karls University of Tübingen in 1992. He was awarded the Paul-Martini-Preis in the same year.

In 1998, he became Professor and Chair of General Pharmacology at the University of Greifswald. From 2000 to 2012, he served as Dean of the Medical Faculty at the same university. From 2012 to 2019, he was Chairman of the Management Board and Dean of the Faculty of Medicine at the University Medical Centre Göttingen.

He has served as a board member of the German Medical Faculty Association since 2007, including as its president from 2012 to 2019. He is also a board member of the Association of German University Hospitals (VUD) and a member of the AAHC President’s Council on Health Security. In 2018, Prof. Kroemer was elected a member of the German National Academy of Sciences Leopoldina, and he is also a member of acatech and the Berlin-Brandenburg Academy of Sciences and Humanities. From 2021 to 2023, he chaired the German Federal Government’s Corona Expert Council, and from 2024 to 2025, he chaired the Expert Council “Health and Resilience”.

Since September 2019, Prof. Kroemer has been Chief Executive Officer of Charité – Universitätsmedizin Berlin, representing the institution in all matters and overseeing its strategic, structural and economic development.

Christian Lattermann MD

  • Endowed Chair and Associate Professor Brigham and Women's Hospital @Harvard University

  • Director of Research Mass General Brigham Sports Medicine

  • President @International Cartilage Repair and Joint Regeneration Society (ICRS)

 

Dr. Lattermann began his orthopaedic training at Hannover Medical School, where he earned his medical doctorate with a thesis in sports medicine. He continued his training at the University of Pittsburgh and Rush Medical Center and is triple fellowship-trained in Sports Medicine, Orthopaedic Trauma, and Orthopaedic Research.

He previously served as Full Professor and Vice Chair for Research at the University of Kentucky before joining Brigham and Women’s Hospital in 2018 as Chief of Sports Medicine. He was instrumental in building the Mass General Brigham Division of Sports Medicine and currently serves as Director of Research. He is Associate Professor at Harvard Medical School and holds the Endowed Brigham and Women’s Chair for Orthopaedics and Sports Medicine.

Dr. Lattermann directs the BWH Cartilage Repair Center and leads the Clinical Orthopaedics, Sports Medicine and Outcomes Research (COSMOS) group, focusing on joint restoration and osteoarthritis. With over 180 peer-reviewed publications and more than 300 national and international presentations, he is an internationally recognized expert in cartilage repair, complex knee reconstruction, and post-traumatic osteoarthritis. He currently serves as President of the International Cartilage Repair and Joint Restoration Society (ICRS).

Prof. Malavika Nair PhD

  • Associate Professor of Biomaterials @University of Oxford

  • Non-Tutorial Fellow @St. Catherine's College Oxford

  • Research Area Lead in Biomedical Materials @Henry Royce Institute

 

Malavika Nair is an Associate Professor of Biomaterials at the University of Oxford’s Institute of Biomedical Engineering. She leads the SMART Biomaterials Team, which develops materials with sensing, adaptive, regenerative, and therapeutic functions for healthcare applications. Trained in Natural Sciences (Materials Science) at Cambridge, her earlier work ranged from collagen scaffolds to machine learning for biomaterials. Alongside her research, she is also heavily engaged with the wider community, and is the current Chair of the UK Joint Biomedical Engineering Steering Group, the Membership Secretary of the IOM3 Biomedical Materials Division, and a Research Area Lead in Biomedical Materials for the Henry Royce Institute.

Featured Speakers

 

Conference Agenda & Schedule

To be released

ATiO Emerging Company Pitch Contest

Welcome to the ATiO Emerging Company Pitch Contest, a premier platform where innovation meets opportunity within the realm of orthopaedics. This exclusive event showcases a handpicked selection of pioneering early-stage products, groundbreaking ideas, and dynamic companies poised to transform the current landscape of medical therapies in orthopaedics. Each participant represents innovative solutions designed to enhance patient care, improve treatment outcomes, and pave the way for a brighter future!
Below, you'll find the confirmed participants of the #ATiOEmergingCompanyPitchContest2026, each a testament to the spirit of innovation that drives the ATiO Conference. We invite you to explore these visionary entities, learn about their groundbreaking work, and witness the future of musculoskeletal therapies!

Latest ATiO Award Winner

Congratulations to Peptilogics represented by Nicholas Pachuda for winning the 4th ATiO Emerging Company Pitch Contest at the ATiO Conference 2025!

Location And Host City

The ATiO Conference 2026 will be hosted on 24. - 26. June in Berlin @Telegraphenamt, Monbijoustraße 11, 10117 Berlin, Germany.

 

ATiO Emerging Company Pitch Contest 2026 — Apply now to pitch at the prestigious ATiO Conference 2026 in Berlin, Germany.
Apply now